KalVista PharmaceuticalsKALV
那斯達克 · USD
13.21
-0.42
(-3.08%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
KalVista PharmaceuticalsKALV
13.21
-0.42
(-3.08%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 0 | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 0 | - | - | - | - | - | - | - | - | - |
營業費用 | 50,016 | 42,939 | 45,811 | 44,215 | 48,455 | 33,151 | 29,746 | 29,093 | 31,728 | 26,945 |
研發費用 | 15,891 | 12,593 | 16,611 | 26,614 | 25,248 | 22,523 | 19,089 | 19,307 | 23,951 | 20,063 |
推銷及管理費用 | 39,139 | 30,346 | 29,200 | 17,601 | 23,207 | 10,628 | 10,657 | 9,786 | 7,777 | 6,882 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -50,016 | -42,939 | -45,811 | -44,215 | -48,455 | -33,151 | -29,746 | -29,093 | -31,728 | -26,945 |
其他收入及費用 | - | 1,520 | 3,544 | 3,772 | 3,806 | 4,123 | 2,096 | 3,776 | 5,423 | 5,642 |
利息費用 | 2,943 | 2,842 | - | - | - | - | - | - | - | - |
稅前純益 | -53,081 | -44,261 | -42,267 | -40,443 | -44,649 | -29,028 | -27,650 | -25,317 | -26,305 | -21,303 |
所得稅 | -855 | 4,247 | - | - | - | - | - | - | - | - |
稅後純益 | -52,226 | -48,508 | -42,267 | -40,443 | -44,649 | -29,028 | -27,650 | -25,317 | -26,305 | -21,303 |
基本每股稅後盈餘(元) | -0.99 | -0.92 | -0.91 | -0.87 | - | -0.84 | -0.80 | -0.74 | -0.77 | -0.75 |
稀釋每股稅後盈餘(元) | -0.99 | -0.92 | -0.91 | -0.87 | -1.07 | -0.83 | -0.80 | -0.74 | -0.75 | -0.74 |
基本平均股數(千股) | 53046.00 | 52638.00 | 46695.00 | 46232.00 | - | 34723.00 | 34565.00 | 34414.00 | 34342.00 | 28278.00 |
稀釋平均股數(千股) | 53046.00 | 52638.00 | 46695.00 | 46232.00 | - | 34723.00 | 34565.00 | 34414.00 | 34342.00 | 28278.00 |
還原基本每股稅後盈餘(元) | -0.99 | -0.92 | -0.91 | -0.87 | - | -0.84 | -0.80 | -0.74 | -0.77 | -0.75 |
還原稀釋每股稅後盈餘(元) | -0.99 | -0.92 | -0.91 | -0.87 | -1.07 | -0.83 | -0.80 | -0.74 | -0.75 | -0.74 |
還原基本平均股數(千股) | 53,046 | 52,638 | 46,695 | 46,232 | - | 34,723 | 34,565 | 34,414 | 34,342 | 28,278 |
還原稀釋平均股數(千股) | 53,046 | 52,638 | 46,695 | 46,232 | - | 34,723 | 34,565 | 34,414 | 34,342 | 28,278 |
EBITDA(千元) | -49,877 | -41,189 | -42,035 | -40,214 | -44,426 | -28,816 | -27,432 | -25,062 | -26,019 | -20,892 |